So-Young International (SY) Q2 2025 Earnings
How Did SY Stock React to Q2 2025 Earnings?
S&P 500 over the same 30 days: +2.45%.
Did SY Beat Earnings? Q2 2025 Results
Yes. So-Young International reported Q2 2025 earnings of $-0.05 a share on Aug 14, 2025, beating the $-0.11 consensus estimate by 53.5%. Revenue was $52.9M against a $362.2M estimate.
Revenue was $52.87 million, below the $373.09 million consensus estimate. EPS was -$0.05, in line with the -$0.11 estimate. So-Young International Inc. reported a net loss of $5.03 million for Q2 2025, compared to a net income of $18.94 million in Q2 2024. The company experienced a 7% decline in total revenues year-over-year, primarily due to a decrease in the number of medical service providers subscribing to its platform. However, revenues from aesthetic treatment services increased significantly by 426.1% to $20.16 million, driven by the expansion of branded aesthetic centers. The company continues to focus on scaling its aesthetic center network and aims to operate 50 centers by year-end. Operating expenses slightly decreased by 1.8% to $33.68 million, reflecting cost management efforts.
- Expansion of branded aesthetic centers.
“During the second quarter, our branded aesthetic centers became the largest contributor to revenue for the first time, a significant milestone in our transformation strategy.”
So-Young International CEO, on the earnings call
What Was So-Young International's Outlook in Q2 2025?
For Q3 2025, So-Young expects aesthetic treatment services revenues to be between $20.9 million and $23.7 million, representing a significant increase from the same period in 2024.
SY YoY Financials
| Metric | Q2 2025 | Q2 2024 | Year over year |
|---|---|---|---|
| Revenue | $52.9M | $407.3M | −87.0% |
| Gross Profit | $27.1M | $252.4M | −89.3% |
SY Revenue by Segment
Figures from SEC filings and company reports. Not investment advice.